Fortis Healthcare Schedules Investor Meetings in New York, Boston, and San Francisco
Fortis Healthcare Limited will hold investor meetings in New York, Boston, and San Francisco from January 12-15, 2026. These meetings, including a J.P. Morgan roadshow and healthcare conference, aim to provide general business and industry updates. No UPSI will be shared.
This is a standard communication regarding investor engagement and does not involve any material new information, financial results, or corporate actions that would directly impact the company's operations or stock price.
The announcement is a routine intimation of investor meetings and does not contain any specific financial performance data or strategic decisions that would significantly alter the company's outlook.
Fortis Healthcare Limited (FHL) has announced a schedule of upcoming investor meetings with its management. These meetings are intended to discuss general business updates and the industry landscape in which the company operates.
The first event is a non-deal roadshow organized by J.P. Morgan, scheduled for January 12 and January 13, 2026. This will take place in New York and Boston, respectively, starting at 09:00 AM onwards (EST). The meetings will be conducted in-person and will include one-on-one and group sessions.
Following the roadshow, Fortis Healthcare will participate in the J.P. Morgan 2026 Healthcare Conference. This event is scheduled for January 15, 2026, in San Francisco, commencing at 08:15 AM onwards (PST). Similar to the roadshow, it will feature in-person one-on-one and group meetings.
Fortis Healthcare has stated that the schedule and timings are subject to change. Importantly, no Unpublished Price Sensitive Information (UPSI) will be shared during these interactions. Any presentation materials prepared for these events will be disclosed to the stock exchanges prior to their commencement.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.